Avg Qtr Burn
Short % of Float
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
|Drug & Indication||Stage & Event||Catalyst Date|
APVO436 (anti-CD123 x anti-CD3) +/- Venetoclax + Azacitidine Details
Myelodysplastic syndrome, Acute myeloid leukemia, Cancer
ALG.APV-527 (4-1BB x 5T4) Details
Cancer, Solid tumor/s, Colorectal cancer , Pancreatic cancer, Non-small cell lung carcinoma, Breast cancer